Nasdaq Moves to Delist Lunai Bioworks Over Equity Requirement
Nasdaq said Lunai Bioworks failed to meet the $2.5 million stockholders’ equity requirement under Listing Rule 5550(b)(1) and determined to delist its securities. Trading could be suspended October 30 unless the company requested a hearing by October 28.
Nasdaq informed the company on October 21, 2026, that it had not met the $2.5 million stockholders' equity threshold in Listing Rule 5550(b)(1) and had decided to delist its securities. Trading could be suspended October 30 unless the company requested a hearing by October 28, which it does…